Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Lexaria Corp. (Lexaria Bioscience Corp.) on August 31, 2008. The company is incorporated in Nevada and maintains its principal address in Vancouver, British Columbia, Canada. The report discloses a material definitive agreement entered into on the date of the report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance agreement rather than financial performance data.
Material Changes
On August 31, 2008, the company entered into a six-month controller agreement with CAB Financial Services, a consulting firm organized under British Columbia law. A material change in corporate structure or operations is noted regarding the engagement of this service provider.
Guidance, Risks, and Related Party Transactions
The filing highlights a related party transaction. CAB Financial Services is controlled by Chris Bunka, who serves as the Chairman of the Board and Chief Executive Officer of Lexaria Corp. The agreement is for a term of six months. The filing does not contain forward-looking guidance, specific risk factors, or details on contingencies beyond the execution of this contract.
Key Facts for Investor Verification
- Lexaria Corp. engaged CAB Financial Services as its controller for a six-month term starting August 31, 2008.
- The service provider is controlled by Chris Bunka, the company's CEO and Chairman, constituting a related party transaction.
- No financial performance metrics or liquidity data are disclosed in this specific filing.
- The agreement is documented in Exhibit 10.1 attached to the filing.